CoreTissue BioEngineering

About:

CoreTissue BioEngineering is a medical care provider through development of artificial ligament and other medical devices.

Website: https://www.coretissue.com/

Top Investors: WERU Investment, Teijin

Description:

CoreTissue BioEngineering is a development of an artificial ligament for reconstruction of the anterior cruciate ligament in Japan.

Total Funding Amount:

560M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Yokohama, Kanagawa, Japan

Founded Date:

2016-11-29

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-02-24

IPO Status:

Private

Industries: